Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT (Mar, 10.1038/s41409-024-02269-4, 2024)
Author(s):
Robin, M.; Iacobelli, S.; Koster, L.; Passweg, J.; Avenoso, D.; Wilson, K.M.O.; Salmenniemi, U.; Dreger, P.; Borne, P. von dem; Snowden, J.A.; Robinson, S.; Finazzi, M.C.; Schroeder, T.; Collin, M.; Eder, M.; Forcade, E.; Loschi, M.; Bramanti, S.; Pérez-Simón, J.A.; Czerw, T.; Polverelli, N.; Drozd-Sokolowska, J.; Raj, K.; Hernández-Boluda, J.C.; Mclornan, D.P.
Published
2024
Publication type
Article / Letter to editor
Date issued
2024-08-31
Language
English
Is part of
Bone Marrow Transplantation (2024), Vol. 59, no. 8, p. 1205-1205
